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1. Introduction 
The powerful ability of proteins to bind selectively its ligand and interact specifically with 
other proteins during its functions, have been employed in the development of highly 
specific and robust biosensors (Medintz and Deschamps 2006; Vallee-Belisle and Plaxco 
2010). To design protein biosensor is required to attach a transducer to the protein in order 
to monitor a specific interaction. The nature of this transducer is diverse, but fluorescent 
attachment has been used extensively by protein, in general are based in attachment in a the 
chemical groups  and/or in the genetical fusion of green fluorescent proteins (GFP) or 
derived proteins (Deuschle, Okumoto et al. 2005; Campbell 2009; Wang, Nakata et al. 2009). 
In this review we are focus in  the fluorescent biosensors based in site-specific fluorescent 
labeling, as a result of combining the chemical attachment by site-directed mutagenesis 
and/ or manipulation of genetic code. Given the enormous diversity in the nature of the 
fluorescent attachment to proteins, we are focused to the recent advances in monitoring 
protein-ligand and protein-protein, and their applications in different areas of research. 
Since the protein scaffold used as biosensor might be a pharmacological target (Cooper 
2003), the design of robust biosensors, could be used for high-throughput screening in the 
search of new drugs (Cooper 2003). 
2. General design of biosensor 
A biosensor is a biological receptor able to monitor the concentration of a specific analyte 
or even more, could be selective to interact only with a particular conformation of a 
macromolecule, event typically associated to the allosteric proteins, that present changes 
in the protein conformation coupled to changes in the affinity for its ligand or another 
proteins (Wang, Nakata et al. 2009). In any case, for the biosensor design is required their 
appropriate transducer, and the nature of this could be diverse: optic, mechano-chemical, 
electro-chemical, acustic, etc. There is no a universal rationale for biosensor construction, 
therefore, should be taken in consideration several features for design: First, is the choice 
for the biological component, in general is a protein that provide the stereospecificity 
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required for the wanted interaction, but in some cases nucleic acids are good sensors 
(aptamers). Enzymes are very specific, however in some cases the catalysis is not 
desirable, thus some enzymes have to be modified to impair the activity and conserve 
only the ligand binding property, or the ideal case is to use a protein that only bind the 
analyte to monitor. Accordingly, a family of proteins in the periplasmic space of bacteria 
fulfill the last requirement (Looger, Dwyer et al. 2003; de Lorimier, Tian et al. 2006). These 
proteins named periplasmic binding proteins (PBPs), present a conformational change 
upon ligand binding, as a first step to interact with a membrane transporters (ABC 
proteins), previous of the translocation of ligand to the interior to the cell (de Lorimier, 
Tian et al. 2006; Medintz and Deschamps 2006; Tsukiji, Miyagawa et al. 2009). The 
different members of these proteins are able to bind a large number of analytes, such a as: 
carbohydrates, amino acids, ions, hormones, heme-groups, etc. Thus several PBPs has 
been used to detect a specific ligand, the group of Hellinga has been able to construct 
constructed several fluorescent biosensors . 
The Second consideration, is about the chemical nature of the fluorescent transducer, and 
the physicochemical property for which the signal is optimal. There are signals very 
sensitive to the polarity of the solvent, or to the electrochemical environment, pH, etc. In 
general several fluorescent groups have solvatochromic effects in which there is a low 
emission fluorescence in aqueous environment, but in low polar environment there is an 
increase of fluorescence emission associated to a blue-shifted emission spectrum. Since, 
when a protein interaction take place, this produce changes in solvent accessibility 
rearrangement of not covalent interaction, thus in many cases the fluorophore may sense the 
environment perturbation produced by the protein interaction. Also, there are fluorescents 
signals that are quenched when a ligand or another protein are in proximity of the label. 
When the protein present a notable conformational change, in some cases a pair donator-
acceptor signals could be selected to generate Foster resonance energy transfer (FRET) 
biosensors, in which the fluorescence transference energy observed by fluorescence emission 
changed in a distance dependence when the conformational change take place. 
Third consideration, is the selection of a position into the protein to introduce the signal, 
these position would generate low perturbation in the stability of the protein with full 
capacity to the specific interaction sought, and high sensitivity for detection, the advantage 
for label introduction by chemical methods, allow to introduce the label at any position of 
the protein. This may be the most difficult problem to predict the best place to introduce the 
signal to produce the high sensitive signal with a low perturbation of the ligand binding 
system. In many cases when the introduction of the signal is closer of the ligand binding 
site, allow the good signal. Now days, the structural  information of proteins allow to 
evaluate in silico the effect of protein stability before the experimental work, from the protein 
data base (PDB), and the identification of structural binding motives or the ability to create a 
structural model from the homologues protein with know structure in combination with 
molecular modelling. A fourth factor to be considered is the robustness of the biosensor, to 
be reproducible, reversible, rapid for signal detection, and reagent free, altogether, these 
characteristics will determine if the designed biosensor could be able to monitor in real time 
in either cell environment or in a immobilized device (Looger, Dwyer et al. 2003; Vallee-
Belisle and Plaxco 2010; Plaxco and Soh 2011). In general there are some advantage and 
limitations for these type of biosensors (Table 1). 
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 Advantage Limitation 
Fluorescent groups 
The chemical nature is 
diverse, many are 
commercial available, is 
possible to select a broad 
range in light excitation in 
the UV, visible spectra. Are 
small and is possible to 
label at any position into 
the protein sequence. 
The stability perturbation 
that may introduce the 
chemical group into the 
protein. 
Position for labeling 
Combined with the site 
directed mutagenesis is 
possible to introduce at any 
position wanted. 
Stability perturbation, and 
undesired reaction, but this 
is overcome with 
incorporation of SH groups 
at specific positions. 
Biological receptor 
There are many ligand 
binding proteins, receptor, 
and enzymes for protein 
selection. 
Modification of the ligand 
binding specificity for its 
ligand. 
Table 1. Advantge and limitation for the inytroduction of fluorescent labels. 
3. Biosensor based in chemical attachment of labels and genetic methods 
The incorporation of fluorescent labels by combination of chemical-labeling methods 
simultaneously with molecular genetic methods are diverse, nonetheless, we can categorize 
in three major groups in terms of the method to label the chemical probe into the protein 
surface: i) incorporation of reactive free cysteine for thiol-fluorescent labeling by site 
directed labeling methods; ii) site specific incorporation of unnatural fluorescent amino acid 
based in a expansion of genetic code methods; and iii) incorporation by covalent chemical 
modification, some by post-photoaffinity labeling from the site directed labeling based in a 
thiol -fluorescent reactive, the signal incorporation could be at binding site (endosteric), 
outsite of the binding site (allosteric) or in the case of two fluorophores for fluorescence 
resonance energy transference (FRET) as described in Fig 1. 
3.1 Biosensor based in site-directed mutagenesis and site-specific fluorescent 
labeling methodology 
The addition of fluorescent signal to a protein by introduction of a reactive cysteine for a 
thiol-fluorescent group is consequence of both, the enormous chemical synthesis available to 
attach covalently fluorescent groups to the SH group present in the cysteine residue of 
proteins, and at the same time the well established molecular genetic methods to introduce a 
new residue by site directed mutagenesis. In particular the thiol groups of a cysteine is the 
most reactive nucleophile of protein residues, thus, is very effective to label only the SH 
residues without non-specific labeling. The large number of fluorescent probes could be 
excited in a broad range of light wavelength from the uv light to the visible range, and 
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Fig. 1. Localization for fluorescent labeling. A, at the binding site, B, in allosteric site, and C, 
two fluorophore incoporation for FRET, when the distance between two signals changed by 
a conformational change..  
several of these probes are commercially available (Toronto Chemical Research Inc., 
Invitrogen-Molecular ProbesTM, Sigma-Aldrich®). The cysteine residue are not frequently 
present in proteins, then, is possible eliminate cysteine residues by site directed mutagenesis 
to avoid unspecific labeling. Site specific labeling of proteins with fluorescent probes, 
requires careful choice of labeling chemistry, optimization of the labeling reaction, the 
complete characterization of labeled proteins for: labeling efficiency, retention of protein 
functionality and minimal structural perturbation (Altenbach, Klein-Seetharaman et al. 1999; 
Mansoor and Farrens 2004). Given that several of the labels are small chemical groups, the 
labeling at relatively exposed residues minimize the perturbation in the protein structure. 
This was demonstrated by Farrens and col by the specific incorporation of bromobimane in 
a helix-turn-helix motive after chemical modification of 21 consecutive single-cysteine 
mutants; the residues T115 to K135 of T4 lysozyme. The ∆∆G calculated from each 21 
mutants and compared with the wild type enzyme indicated a minimal energy perturbation 
≤ 1.5 kcal/mol, for those residues exposed ≥ 40 Å of solvent surface accessible, after 
chemical modifications. In this work was pointed out no energy destabilization of T4 
lysozyme after fluorophore labeling unless the residue was buried into the protein structure. 
Thus having information about the protein topology, or the structure  ligand binding 
domain, there is a good possibility to introduce a small fluorescent signal with low 
perturbation in the designed protein. 
3.2 Biosensor based in the insertion of non-natural amino-acids 
The use of amber stop codons has been allowed to acylate the tRNA with un-natural amino 
acids and enrich its chemical  repertory into a protein. In addition to this method Honsaka 
and col has been developed the four base pare method to incorporate unnatural amino 
acids, among them have been synthesized p-aminophenylalanine derivatives bound to 
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BODIPY fluorophore. This approach was applied to incorporate two variants of fluorescent 
amino acids to calmodulin, an energy donor acceptor pair, to demonstrate the feasibility for 
FRET measurements when the distance between pairs change upon addition of calmodulin 
binding protein. This method allowed to study in solution the dynamics of the 
conformational change of calmodulin. 
3.3 Biosensor based in post transcription modifications and chemical modification 
Introducing a fluorescent signal without knowing about the sequence or the three 
dimensional structure, or binding domains for obtain a functional biosensor could be a very 
hard task,  Hamachi and collaborators introduce the post-photoaffinity labeling 
modification (P-PALM) to introduce fluorescent molecule close of the active site of a enzyme 
without any genetic manipulation to introduce the signal into the protein (Nagase, Nakata 
et al. 2003; Nakata, Nagase et al. 2004). The main goal of this methodology to attach 
fluorescent labels in living cells or whole organisms, that is the reason to avoid genetic 
methods. Based in this approach this group developed a biosensor based in the scaffold of a 
lectin, a saccharide binding protein. To this end concavalin A (Con A) was used in presence 
of the P-PALM reagent. This reagent have three important characteristics (Fig. 2): 1) high 
affinity to the lectine, a saccharide moiety, to bind the Con A, 2) the photoactive moiety 
(diazirine) to label the protein by photoirradiation, and 3) a disulfide group to remove the 
original ligand to bind to the protein and allow at the same time a reactive site for chemical 
modification (the thiol group).  
In other words the P-PALM is bounded to the protein by UV light irradiation when the 
ligand is anchored to the binding site of ConA by the saccharide moiety, then a reduction of 
the probe, generate a reactive SH for covalent modification with a thiol-reactive fluorophore, 
such as dansyl or fluorescein groups, then this lectin is transformed in fluorescent biosensor 
to saccharide (Fig 3). 
 
 
Fig. 2. P-PALM reactive and target. A is the molecular estructure of a post-photoaffinity 
labeling reagent P-PALM, and B is the structure of the target the concanalin A, the PDB Is is 
1 VAM. 
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The advantage of this method is the introduction of several chemical labels without need 
to use genetic engineered methods (Fig. 3), with the additional property to attach several 
fluorescent moieties. For example the addition of the fluorescent pH indicator, SNARF, 
the biosensor was able to distinguish to differentiate several anomeric groups present in 
the saccharides (Nakata, Nagase et al. 2004; Ojida, Miyahara et al. 2004). The same group 
of Hamachi and collaborators has been developed a similar methodology, now based in 
the chemistry of tosyl group, named ligand directed tosyl (LDT) chemistry (Tsukiji, 
Miyagawa et al. 2009) that contained benzenesulfoamide as the specific moiety. This allow 
to synthesize tosyl derivatives that bind specifically to some proteins: carbonic anhydrase, 
FK506-binding protein, or congerin (beta-galactoside-binding lectin). This strategy was 
applied successfully to create biosensor in vitro, and inside the cells without genetic 
modification methodology. The applications around this methodologies are versatile, for 
example another development by the same group is the quenched ligand directed toysil 
(Q-LDT) chemistry (Tsukiji, Miyagawa et al. 2009; Tsukiji, Wang et al. 2009; Wang, Nakata 
et al. 2009), in this case after the photolabeling, the fluorescent signal is quenched, but 
when the ligand interact in the binding site, the quencher is released from the protein, and 
the increase of fluorescence signal is used to do a calibration of the ligand concentration in 
solution. 
 
 
Fig. 3. Schema for the fluorescent labeling with a P-PALM reactive. In step 1 the P-PALM 
binds to the protein by photoirradiation, 2 reduction of the sample prepare a SH free and in 
3, the fluorophores by specific chemical modification to SH group. 
4. Biosensors for protein-ligand based in conformational changes 
Several protein changed the conformation locally of globally when a ligand binds, this is in 
part explained by the conformational displacement or induced fit mechanisms present in 
proteins. Accordingly to recent view for the dynamical properties of proteins, from nuclear 
magnetic resonance (NMR) and molecular dynamics algorithms, it have been proposed that 
proteins are in dynamical equilibrium, and the presence of ligand should stabilize one of the 
extreme states. In this dynamics equilibrium point of view, several non-covalent 
interactions, such as hydrogen bound, hydrophobic interactions or van del Walls 
interactions are created  at expenses to remove other interactions in different part of the 
protein, in a coupled process to the ligand binding event, in this sense if a suitable 
fluorescent signal is located into protein carring out the conformational change, should be 
an ideal for biosensor design when a fluorescent transducer is attached to the protein. The 
family of periplasmic binding proteins (PBPs) that presented a conformational change upon 
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ligand binding has been used to create diverse biosensors based in the fluorescent 
incorporation by chemical modification with thiol-fluorescent reactive for cysteine. This 
work has been pioneered by Cass and col by introduction of fluorescent group into the 
maltoside binding protein (MBP) a PBP, and extensively developed by Hellinga and 
collaborators (de Lorimier, Smith et al. 2002). This family of proteins presented a bilobated 
structure with high similarity, that present at least two conformers: an open form in absence 
of ligand and a closed state bound to its ligand (Fig. 4). Given that the different member of 
this family are able to bind a diverse number of ligands, it have been developed a big 
number of biosensor for diverse ligands such as glucose, ribose, aminoacid,  ions etc.  
In the same line of research Hellinga and col. have been employed member of PBPs to 
developed approximately 300 different biosensor, by introduction of the signal in the 
binding site, or near of remote from the binding site, for example into the hinge that connect  
the structure of the two lobules in PBPs. 
 
+ Ligand 
Open Closed 
 
Fig. 4. Conformationa change present upon ligand binding in the maltoside binding protein, 
the PDD ID for open state is 1N3X  and for the closed state is 1NL5. 
The introduction of signal in the endosteric or allosteric sites allow to calibrate some of the 
signals to the concentration of ligand in solution, however only 4% of the 320 biosensor 
changed the fluorescence intensity to develop highly sensitive biosensor (Fig. 4). To improve 
the detection of the signal transduction, it was analyzed the molecular nature of 
fluorescence environment from a structural model for the maltose binding proteins and 
modified the fluorophore environment into the protein by site directed-mutagenesis, this 
study allow a increase in 400% of the signal intensity or signal, that point out the use of 
molecular modelling to improve the transduction signal to a high sensitive levels 
(Dattelbaum, Looger et al. 2005).  
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5. Biosensor to monitor protein-protein interactions 
Specific protein–protein interactions are required for cellular communication processes, 
such as signal transduction cascades, transcription events, or transport process, etc. The 
determination of crystallographic structure of the protein complexes is not necessarily 
enough to explain the molecular basis of their specific interactions, therefore for a more 
dynamic study of protein-protein interactions in solution is combined with the introduction 
of labels in or near of interaction surface for the protein complex with structural models. For 
example, the use of fluorescent labels covalently attached for the proteins that participate of 
the primary events during the coagulation cascade were carried out; the interaction of the 
extracellular tissue factor (soluble TF) and the activated factor VII (Owenius, Osterlund et al. 
2001). The results of this work indicated that the multi-probe methodology permits to obtain 
indirect binding constants between the two proteins in solution, and it was concluded that 
the tightness of the local interactions at the labeled positions was similar to the interactions 
detected inside of the interior of globular proteins.  
The interface of actin myosin complex monitored by site-directed fluorescence and spin 
labeling techniques revealed a more complicated point of view for the interacting forces 
required for the active complex formation (LaConte, Voelz et al. 2002). The hypothesis of a 
simple transition of disordered weak interactions to strong-ordered interactions during the 
actin-myosin complex was not consistent with experimental. A strong-complex formation 
was indicated by a decrease in the mobility of the labels, but the labeled myosin indicated 
high mobility even after complex formation, also, solvent accessibility surface was decreased 
for actin-bound labels although was increased for myosin-bound probes. 
The photoreceptor rhodopsin present a conformational change activated by light in order to 
form an active state (named MII). This state, interact and activated the G protein transducin 
for the initiation of the biochemical cascade during the vision process (Filipek, Stenkamp et 
al. 2003). Interactions of both proteins were monitored by the changes in the fluorescence of 
bimane specifically incorporated into the rhodopsin, with the carboxylic terminus of a G 
protein transducin (Janz and Farrens 2004), given that the tryptophan residue quenches the 
bimane fluorescence (Mansoor, McHaourab et al. 2002), this interaction is able to monitor 
protein-protein interactions or conformational changes in proteins. Mapping the interaction 
of tryptophan with bimane by fluorescence quenching in solution between rhodopsin and 
transducin, was detected the presence of a critical hydrophobic interaction that controls the 
affinity of this specific interaction (Janz and Farrens 2004). In a similar study for the binding 
and release of the arrestin to the photoreceptor rhodopsin were monitored in real time by 
the changes in the fluorescence spectra of arrestin labeled with bromobimane at the 
proposed surface-binding site of rhodopsin with the arrestin (Janz and Farrens 2004). These 
studies proposed that arrestin and retinal release from the rhodopsin receptor are a linked 
process (Sommer, Smith et al. 2005); thus, this innovative methodology has been used for 
study the dynamics of arrestin interactions on the mechanism of G-protein-coupled 
receptors (Sommer, Smith et al. 2006) which are the target of a big number of drugs designs. 
6. Biosensor for robust detection of ligand interactions and drug design 
Calmoduilin is a calcium binding proteins that interact with many cellular targets including 
soluble enzymes, ion-channels and primary pumps, resulting in a variety of essential 
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downstream cellular effects (O'Neil and DeGrado 1990; Weinstein and Mehler 1994; Zhang 
and Yuan 1998; Zielinski 1998; Carafoli and Klee 1999; Berridge,  et al. 2003), and the 
conformation of the protein which drastically change according to the calcium levels into 
the cell to regulate physiological processes (Fig. 5), therefore this protein represents an 
important drug target (Dagher,  et al. 2006). Indeed, many CaM inhibitors are well known 
antipsychotic, smooth muscle relaxants, antitumoral and α-adrenergic blocking agents, 
among others. The interaction of CaM with its physiological targets depends on the 
exposure of two hydrophobic pockets (Fig. 5) following the conformational change elicited 
by Ca2+-binding to the protein. 
 
 
 
 
 
 
 
 
 
 
 A B C 
 
Fig. 5. Three-dimensional structures of the CaM in its different conformations: A) calcium-
free (pdb code: 1CFD); B) with calcium (pdb code: 1CLL) and; C) with TFP (pdb code: 1LIN). 
The structures were drawn using the PyMOL program. 
Many compounds including drugs, pesticides and research tools interact with CaM at the 
same hydrophobic sites provoking also conformational changes in the protein. Many of 
these substances behave as CaM antagonists, the best known structural examples of these 
interactions are the antipsychotic analogs of trifluoroperazine (Gangopadhyay, et al. 2004). 
In this sense several CaM has been used a protein target to interact with several protein by 
fluorescent attachment, for example: interaction between calmodulin (CaM) and a CaM-
binding peptide of the ryanodine receptor (CaMBP) and its sub-fragments F1, has been 
measured by the mutant Thr31Cys with the fluorescent group badan attached (Sharma, Deo 
et al. 2005). A mutant of CaM coupled to three different environment-sensitive fluorophores 
(MDCC, acrylodan, and IANBD ester) was detected the CaM interaction with 
phenothiazines and related tryclic antidepressants (Douglass, Salins et al. 2002). Recently  
Gonález-Andrade and col, has been designed a alternative biosensing assay for CaM 
inhibitors by chemical modification of bromobimane at position 124 (Gonzalez-Andrade,  et 
al. 2009; Figueroa,  et al. 2010), that allowed to determine the IC50 and Kd of the CaM 
inhibitors in a same fluorescent assay Fig 6. 
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Fig. 6. Structural moeling of the trifluoroperazine into the binding site of calmodulin and 
fluoresence titration to compare with fluorescent changes. 
7. Conclusions 
The well established method to attach fluorescent labels into the structure of a protein 
mentioned above by chemical methods in combination in some cases with the molecular 
biology methodologies, is making available a broad number of proteins to monitor a diverse 
protein interactions.  The selection of a protein receptor that should be a target form drug 
design for example the case of G protein coupled receptors (GPCR), that represent  close of 
the 30 % of the drug market, or calmoduilin that participates in a large number of protein 
signals, provided a excellent protein receptor to be adapted in robust protein immobilization 
methods required in the development of new strategies in the drug research by high 
throughput screening. 
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